Published Date: 15 Nov 2026
Hedayati recommends shared decision making and a 4 to 6 week treatment trial, stopping therapy when patients don’t respond.
Read Full NewsMind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with James F. Sumowski, PhD. [LISTEN TIME: 21 minutes]
Laurie Gutmann, MD, chair of the Department of Neurology at Indiana University School of Medicine, discusses one-year pooled ACHIEVE data for z-basivarsen (DYNE-101), an investigational antisense oligonucleotide, in myotonic dystrophy type 1 (DM1).
PAES data from ASN Kidney Week 2026 show graft, patient, and kidney function outcomes at 1 year in crossmatch-positive transplants.
ZEUS: Ziltivekimab Fails to Reduce Cardiovascular Events in ASCVD and CKD
ABCs in Dermatology: Rethinking Corticosteroid Stewardship in Chronic Hand Eczema
1.
GLP-1 receptor agonists, cancer risk and questionable significance
2.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
3.
The risk of cancer is decreased by following international health recommendations.
4.
AI is equally capable of reading breast cancer scans as human radiologists.
5.
Discovery of estrogen receptor 'switches' may aid breast cancer treatment
1.
Epigenome Reprogramming in Cancer: Mechanisms, Clinical Translation, and Therapeutic Opportunities
2.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
3.
Geriatric Oncology and Treatment Sequencing: Evidence-Based Approaches for the Aging Cancer Population
4.
Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies
5.
The Algorithmic Oncologist: A Comparative Clinical Review of AI in Predictive Cancer Planning
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Recognizing the Signs of Anemia in Adults
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
3.
Recognizing Symptoms That May Require Cancer Evaluation
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation